LifeStance Health GroupLFST +3.58%56 Receivables Turnover is 3.69 as of Mar. 2026. GuruFocus rates LFST with a GF Score™ of 56/100 and a GF Value™ of $8.23 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 656 Healthcare Providers & Services companies, LifeStance Health Group ranks better than 71.04% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. LifeStance Health Group's Revenue for the
three
months ended in Mar. 2026 was $403 Mil. LifeStance Health Group's average Accounts Receivable for the
three
months ended in Mar. 2026 was $109 Mil.
Hence, LifeStance Health Group's Receivables Turnover for the
three
months ended in Mar. 2026 was 3.69.
LifeStance Health Group (NAS:LFST) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
LifeStance Health Group Receivables Turnover Related Terms
LifeStance Health Group Receivables Turnover Historical Data
* Premium members only.
The historical data trend for LifeStance Health Group's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group Receivables Turnover Chart
LFST vs CON, BKD, OPCH: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, LifeStance Health Group's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group (LFST) has a Receivables Turnover of 3.69 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on LifeStance Health Group and its competitors. According to the industry distribution chart, LifeStance Health Group ranks #190 out of 656 companies in the Healthcare Providers & Services industry, placing it in the top 29%.
Is LifeStance Health Group's Receivables Turnover too high?
LifeStance Health Group's current Receivables Turnover is 3.69. The Healthcare Providers & Services industry median Receivables Turnover is 7.68. LifeStance Health Group's value of 3.69 is 52% below this industry median. Based on the distribution chart, LifeStance Health Group ranks #190 out of 656 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Receivables Turnover compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #190 out of 656 companies for Receivables Turnover. This puts LifeStance Health Group in the upper half of its industry. The industry median Receivables Turnover is 7.68. LifeStance Health Group's value of 3.69 is 52% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.68, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current Receivables Turnover of 3.69 is 52% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Receivables Turnover is 3.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Significantly Overvalued. The stock's GF Value™ is $8.23, compared to a current price of $10.71 — trading 30.1% above its estimated fair value. The current Receivables Turnover is 3.69 and 52% below the Healthcare Providers & Services industry median of 7.68. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Receivables Turnover is 3.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $10.71 is trading 30.1% above its estimated GF Value™ of $8.23.
GuruFocus considers LifeStance Health Group to be Significantly Overvalued.
Key valuation signals for LFST:
Receivables Turnover: 3.69
GF Value™: $8.23 vs. price of $10.71 (30.1% above fair value)
Industry Position: 52% below the Healthcare Providers & Services median (#190 of 656)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score
Get the complete analysis for LFST
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
